Better Business Bureau

Charity Contact Information BBB Wise Giving Alliance Comments Programs

Tax Status Governance Fund Raising Financial

Name:	American Brain Tumor Association
Address:	8550 West Bryn Mawr Avenue, Suite 550
	Chicago, IL 60631
Phone:	847-827-9910
Web Address:	www.abta.org

American Brain Tumor Association (ABTA) does not meet the following Standard for Charity Accountability.

Standard 7: Board Approval of Written Report on Effectiveness - Submit to the organization's governing body, for its approval, a written report that outlines the results of the aforementioned performance and effectiveness assessment and recommendations for future actions. ABTA does not meet this Standard because: It has not completed an effectiveness assessment in the past two years.

ABTA meets the remaining 19 Standards for Charity Accountability.

Through ABTA's research and grant program, new and early career scientists are encouraged to enter and remain in the field of brain tumor research. The program also helps to promote information exchanges between scientists, clinicians, and other healthcare professionals. In 2011-2012, ABTA plans to support 26 research fellows, 2 translational grants, 12 discovery grants, 15 medical student summer fellowships, and several collaborative research opportunities across the United States and Canada. The organization’s Helpline supports families coping with a brain tumor diagnosis. The Helpline provides information to brain tumor patients, families, and care partners. Individualized telephone consultation is also provided by Master's level clinicians who provide guidance through diagnosis, treatment, and palliative care. Furthermore, ABTA provides TrialConnect™ in partnership with Emerging Med and it reports that the service is free and personalized and that it matches a patient’s brain tumor type and treatment history with an appropriate clinical trial. For those who qualify to participate, clinical trial volunteers gain access to new research treatments before they are widely available, play an active role in their own health care, and obtain medical care at health care facilities during the trial. TrialConnect™ helps patients who want to help others by contributing to brain tumor-related medical research and new technologies.

For the fiscal year ended June 30, 2010, ABTA's program expenses were:

Research programs	2,638,057
Patient services	404,232
Total Program Expenses:	$3,042,289

Chief Executive : Elizabeth M. Wilson, Executive Director

Compensation*:

$130,000

Chair of the Board: Claudette Yasell
Chair's Profession / Business Affiliation: Chief Editor, Imaging Life magazine; Siemens Healthcare, Molecular Imaging

Board Size: 12

Paid Staff Size: 19

*July 1, 2009 - June 30, 2010 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.

Method(s) Used:

Direct mail, special events, print advertisements, grant proposals, Internet appeals, and planned giving.

Fund raising costs were 16% of related contributions. (Related contributions, which totaled $3,734,242, are donations received as a result of fund raising activities.)

This organization is tax-exempt under section 501(c)(3) of the Internal Revenue Code. It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.

The following information is based on ABTA's audited financial statements for the fiscal year ended June 30, 2010.

Source of Funds
Contributions	3,693,840
Net realized and unrealized gain on investments	144,082
Other income	113,779
Interest income	66,987
Inventory sales, net	51,927
Fundraising activities, net	40,402
Total Income	$4,111,017

Uses of Funds as a % of Total Expenses

Programs: 79%  Fund Raising: 15%  Administrative: 6%

Total income				$4,111,017
	Program expenses			$3,042,289
	Fund raising expenses			585,530
	Administrative expenses			249,110
Total expenses				$3,876,929
Income in Excess of Expenses				234,088
Beginning net assets				2,748,642
Ending net assets				2,982,730
Total liabilities				211,759
Total assets				$3,194,489